FDA Orange Book · active-ingredient family
Atropine; pralidoxime chloride
Atropine; pralidoxime chloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DUODOTE · NDA 021983
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DUODOTERLD | MMT | NDA 021983 | — | Sep 28, 2006 | |
| ATNAA | US ARMY | NDA 021175 | — | Jan 17, 2002 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Atropine; pralidoxime chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

